Resveratrol Inhibits Pseudorabies Virus Replication by Targeting IE180 Protein. 2022

Xiangxiu Chen, and Xu Song, and Lixia Li, and Yaqin Chen, and Renyong Jia, and Yuanfeng Zou, and Hongping Wan, and Ling Zhao, and Huaqiao Tang, and Cheng Lv, and Xinghong Zhao, and Zhongqiong Yin
Natural Medicine Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, China.

Resveratrol is a natural polyphenolic product in red wine and peanuts and has many pharmacological activities in humans. Our previous studies showed that resveratrol has good antiviral activity against the pseudorabies virus (PRV). However, little is known about the antiviral mechanism of resveratrol against PRV. In this study, we found that resveratrol inhibited the nuclear localization of IE180 protein, which is an important step for activating early/late genes transcription. Interestingly, the results show that resveratrol inhibited the activity of IE180 protein by dual-luciferase assay. Furthermore, molecular docking analysis shows that resveratrol could bind to the Thr601, Ser603, and Pro606 of IE180 protein. Point mutation assay confirmed that resveratrol lost its inhibition activity against the mutant IE180 protein. The results demonstrate that resveratrol exerts its antiviral activity against PRV by targeting the Thr601/Ser603/Pro606 sites of IE180 protein and inhibiting the transcriptional activation activity of IE180 protein. This study provides a novel insight into the antiviral mechanism of resveratrol against herpes viruses.

UI MeSH Term Description Entries

Related Publications

Xiangxiu Chen, and Xu Song, and Lixia Li, and Yaqin Chen, and Renyong Jia, and Yuanfeng Zou, and Hongping Wan, and Ling Zhao, and Huaqiao Tang, and Cheng Lv, and Xinghong Zhao, and Zhongqiong Yin
July 1997, Journal of virological methods,
Xiangxiu Chen, and Xu Song, and Lixia Li, and Yaqin Chen, and Renyong Jia, and Yuanfeng Zou, and Hongping Wan, and Ling Zhao, and Huaqiao Tang, and Cheng Lv, and Xinghong Zhao, and Zhongqiong Yin
February 2024, Food & function,
Xiangxiu Chen, and Xu Song, and Lixia Li, and Yaqin Chen, and Renyong Jia, and Yuanfeng Zou, and Hongping Wan, and Ling Zhao, and Huaqiao Tang, and Cheng Lv, and Xinghong Zhao, and Zhongqiong Yin
July 1994, Virology,
Xiangxiu Chen, and Xu Song, and Lixia Li, and Yaqin Chen, and Renyong Jia, and Yuanfeng Zou, and Hongping Wan, and Ling Zhao, and Huaqiao Tang, and Cheng Lv, and Xinghong Zhao, and Zhongqiong Yin
February 1998, Veterinary microbiology,
Xiangxiu Chen, and Xu Song, and Lixia Li, and Yaqin Chen, and Renyong Jia, and Yuanfeng Zou, and Hongping Wan, and Ling Zhao, and Huaqiao Tang, and Cheng Lv, and Xinghong Zhao, and Zhongqiong Yin
June 2020, RNA biology,
Xiangxiu Chen, and Xu Song, and Lixia Li, and Yaqin Chen, and Renyong Jia, and Yuanfeng Zou, and Hongping Wan, and Ling Zhao, and Huaqiao Tang, and Cheng Lv, and Xinghong Zhao, and Zhongqiong Yin
April 2010, Archives of virology,
Xiangxiu Chen, and Xu Song, and Lixia Li, and Yaqin Chen, and Renyong Jia, and Yuanfeng Zou, and Hongping Wan, and Ling Zhao, and Huaqiao Tang, and Cheng Lv, and Xinghong Zhao, and Zhongqiong Yin
August 2004, The Journal of general virology,
Xiangxiu Chen, and Xu Song, and Lixia Li, and Yaqin Chen, and Renyong Jia, and Yuanfeng Zou, and Hongping Wan, and Ling Zhao, and Huaqiao Tang, and Cheng Lv, and Xinghong Zhao, and Zhongqiong Yin
November 2014, mBio,
Xiangxiu Chen, and Xu Song, and Lixia Li, and Yaqin Chen, and Renyong Jia, and Yuanfeng Zou, and Hongping Wan, and Ling Zhao, and Huaqiao Tang, and Cheng Lv, and Xinghong Zhao, and Zhongqiong Yin
September 2018, Antiviral research,
Xiangxiu Chen, and Xu Song, and Lixia Li, and Yaqin Chen, and Renyong Jia, and Yuanfeng Zou, and Hongping Wan, and Ling Zhao, and Huaqiao Tang, and Cheng Lv, and Xinghong Zhao, and Zhongqiong Yin
June 2021, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!